FDA Issues Draft Guidance on Postmarket Surveillance of Moderate, High-Risk Medical Devices
- May 28, 2021
The Food and Drug Administration (FDA) released May 26 two draft guidance documents on postmarket surveillance of moderate and high-risk medical devices and on post-approval study procedures.
ARTICLE TAGS
You must be logged in to access this content.